SMTL ID : 3o23.1

Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x MQY: (5S)-5-methyl-1-(quinolin-4-ylmethyl)-3-{4-[(trifluoromethyl)sulfonyl]phenyl}imidazolidine-2,4-dione(Non-covalent)

MQY.1: 20 residues within 4Å: Chain A: A.50, K.52, M.73, F.76, V.81, V.82, M.98, E.99, L.100, M.101, G.104, L.145, F.150, H.152, M.161, I.170, G.171, D.172, F.173, M.175 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.82, A:D.172 Hydrogen bonds: A:M.101, A:D.172 Water bridges: A:K.52 Halogen bonds: A:I.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lesuisse, D. et al., Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-05-04

Peptides

Insulin-like growth factor 1 receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Insulin-like growth factor 1 receptor